Class I - Dangerous
Lack of Assurance of Sterility
Pine Pharmaceuticals
Class I - Dangerous
Lack of Assurance of Sterility
Class I - Dangerous
Lack of Assurance of Sterility
Class I - Dangerous
Lack of Assurance of Sterility
Class I - Dangerous
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Class I - Dangerous
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Class I - Dangerous
Lack of Assurance of Sterility
Class I - Dangerous
Lack of Assurance of Sterility
Class I - Dangerous
Lack of Assurance of Sterility
Class I - Dangerous
Lack of Assurance of Sterility
Class I - Dangerous
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.
CGMP Deviations: Raw material recalled by repackager, due to discoloration.
Lack of Assurance of Sterility
Class I - Dangerous
Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for incorrect product.
Class I - Dangerous
Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Class I - Dangerous
Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Class I - Dangerous
Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Class I - Dangerous
Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.